Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

49.22
Delayed Data
As of Sep 22
 +0.16 / +0.33%
Today’s Change
30.89
Today|||52-Week Range
49.45
+37.26%
Year-to-Date

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 48.87, with a high estimate of 56.06 and a low estimate of 32.44. The median estimate represents a -0.71% decrease from the last price of 49.22.

Analyst Recommendations

The current consensus among 31 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since September, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.60
Sales
$4.4B
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.78%
 
 
 
 
 
 
Growthannually 15.26%
 
 
 
 
 
 

Sales

Growthquarterly -3.47%
 
 
 
 
 
 
Growthannually 13.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.